Prognostic factors in a large multi-institutional series of papillary renal cell carcinoma

BJU International

Volumn 109, Issue 8, 2012, Pages 1140-1146

  Zucchi, Alessandro ^a   Novara, Giacomo ^b   Costantini, Elisabetta ^a   Antonelli, Alessandro ^c   Carini, Marco ^d   Carmignani, Giorgio ^e   Cunico, Sergio Cosciani ^c   Fontana, Dario ^f   Longo, Nicola ^g   Martignoni, Guido ^h   Minervini, Andrea ^d   Mirone, Vincenzo ^g   Porena, Massimo ^a   Roscigno, Marco ⁱ   Schiavina, Riccardo ^j   Simeone, Claudio ^c   Simonato, Alchiede ^e   Siracusano, Salvatore ^k   Terrone, Carlo ^l   Ficarra, Vincenzo ^b  

^a UNIVERSITY OF PERUGIA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c UNIVERSITY OF BRESCIA   (Italy)

^d UNIVERSITY OF FLORENCE   (Italy)

^e UNIVERSITY OF GENOA   (Italy)

^f UNIVERSITY OF TURIN   (Italy)

^g UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^h UNIVERSITY OF VERONA   (Italy)

ⁱ VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^j UNIVERSITY OF BOLOGNA   (Italy)

^k UNIVERSITY OF TRIESTE   (Italy)

^l UNIVERSITY OF EASTERN PIEDMONT   (Italy)

more..

Author keywords

Papillary renal cell carcinoma; Prognostic factors

Indexed keywords

ADULT; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER PROGNOSIS; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CANCER SURGERY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PAPILLARY CARCINOMA; PARTIAL NEPHRECTOMY; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY;

ACADEMIC MEDICAL CENTERS; CARCINOMA, RENAL CELL; CAUSE OF DEATH; FEMALE; FOLLOW-UP STUDIES; HUMANS; ITALY; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEPHRECTOMY; PREVALENCE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TIME FACTORS;

EID: 84860396898     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2011.10517.x     Document Type: Article

References (21)

1. Kovacs G, Akhtar M, Beckwith BJ et al. The Heidelberg Classification of renal cell tumours. J Pathol 1997; 183: 131-31
2. Ficarra V, Brunelli M, Cheng L et al. Prognostic and therapeutic impact of the histopathologic definition of parenchymal epithelial renal tumors. Eur Urol 2010; 58: 655-68
3. Delahunt B, Eble JN. Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors. Mod Pathol 1997; 10: 537-44 (Pubitemid 27293491)
4. Mejean A, Hopirtean V, Bazin JP et al. Prognostic factors for the survival of patients with papillary renal cell carcinoma: meaning of histological typing and multifocality. J Urol 2003; 170: 764-7 (Pubitemid 36999550)
5. Kuroda N, Toi M, Hiroi M et al. Review of papillary renal cell carcinoma with focus on clinical and pathobiological aspects. Histol Histopathol 2003; 18: 48
6. Cheville JC, Lohse CM, Zincke H, Weaver AL, Blute ML. Comparison of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol 2003; 27: 612-24 (Pubitemid 36514472)
7. Gontero P, Ceratti G, Guglielmetti S et al. Prognostic factors in a prospective series of papillary renal cell carcinoma. BJU 2008; 102: 697-702
8. Klatte T, Pantuck AJ, Said JW et al. Cytogenetic and molecular tumor profiling for type 1and type 2 papillary renal cell carcinoma. Clin Cancer Res 2009; 15: 1162-9
9. Delahunt B, Eble JN, McCredie MR et al. Morphologic typing of papillary renal cell carcinoma: comparison of growth kinetics and patient survival in 66 cases. Hum Pathol 2001; 32: 590-5 (Pubitemid 32601240)
10. Pignot G, Elie C, Conquy S et al. Survival analysis of 130 patients with papillary renal cell carcinoma: prognostic utility of type 1 and type 2 subclassification. Urology 2007; 69: 230-5 (Pubitemid 46274917)
11. Patard JJ, Leray E, Rioux-Leclercq N et al. Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience. J Clin Oncol 2005; 23: 2763-71 (Pubitemid 46179466)
12. Herrmann E, Trojan L, Becker F et al. Prognostic factors of papillary renal cell carcinoma: results from a multi-institutional series after pathological review. J Urol 2010; 183: 460-6
13. Margulis V, Tamboli P, Matin SF, Swanson DA, Wood CG. Analysis of clinicopathologic predictors of oncologic outcome provides insight into the natural history of surgically managed papillary renal cell carcinoma. Cancer 2008;112: 1480-8 (Pubitemid 351441160)
14. Eble JN, Sauter G, Epstein JI. Classification of tumours: pathology and genetics of tumours of the urinary system and male genital organs. World Health Organization Classification of Tumours, Lyon: IARCC Press, 2004
15. Lefèvre M, Couturier J, Sibony M et al. Adult papillary renal tumor with oncocytic cells: clinicopathologic, immunohistochemical, and cytogenetic features of 10 cases. Am J Surg Pathol 2005; 29: 1576-81
16. Patard JJ, Leray E, Cindolo L et al. Multi-institutional validation of a symptom based classification for renal cell carcinoma. J Urol 2004; 172: 858-62 (Pubitemid 39096407)
17. Greene FL, Gospodarowicz M, Wittekend C et al. American Joint Committee on Cancer (AJCC) Staging Manual, 7th edn. Philadelphia, PA: Springer, 2009
18. Fuhrman S, Lasky LC, Limas L. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982; 6: 655-63 (Pubitemid 13234762)
19. Novara G, Ficarra F, Antonelli A et al. Validation of the 2009 TNM version in a large multi-institutional cohort of patients treated for renal cell carcinoma: are further improvements needed? Eur Urol 2010; 58: 588-95
20. Klatte T, Anterasian C, Said JW et al. Fuhrman grade provides higher prognostic accuracy than nucleolar grade for papillary renal cell carcinoma. J Urol 2010; 183: 2143-7
21. Sika-Paotonu D, Bethwaite PB, McCredie MRE et al. Nucleolar grade but not Fuhrman grade is applicable to papillary renal cell carcinoma. Am J Surg Pathol 2006; 30: 1091-6 (Pubitemid 44299341)